Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors

被引:96
|
作者
Sunderkoetter, C. [1 ]
Herrgott, I. [1 ]
Brueckner, C. [2 ]
Moinzadeh, P. [3 ]
Pfeiffer, C. [4 ]
Gerss, J. [5 ]
Hunzelmann, N. [3 ]
Boehm, M. [1 ]
Krieg, T. [3 ]
Mueller-Ladner, U. [6 ]
Genth, E. [7 ]
Schulze-Lohoff, E. [8 ]
Meurer, M. [4 ]
Melchers, I. [9 ]
Riemekasten, G. [2 ]
机构
[1] Univ Munster, Dept Dermatol, D-48149 Munster, Germany
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Univ Cologne, Dept Dermatol & Venerol, Cologne, Germany
[4] Dresden Univ Hosp, Dept Dermatol, Dresden, Germany
[5] Univ Munster, Coordinating Ctr Clin Trials, Dept Med Informat & Biomath, D-48149 Munster, Germany
[6] Univ Giessen, Kerckhoff Clin, Dept Rheumatol & Clin Immunol, Bad Nauheim, Germany
[7] Univ Aachen, D-5100 Aachen, Germany
[8] Hosp Cologne Merheim, Med Clin 1, Cologne, Germany
[9] Univ Med Ctr Freiburg, Clin Res Unit Rheumatol, Freiburg, Germany
关键词
digital ulcers; German Network; Raynaud's phenomenon; risk factors; systemic sclerosis; RAYNAUDS-PHENOMENON; GERMAN NETWORK; SCLERODERMA TRIALS; ILOPROST TREATMENT; DISEASE; PATHOPHYSIOLOGY; CONSEQUENCES; DERMATOLOGY; MULTICENTER; MANAGEMENT;
D O I
10.1111/j.1365-2133.2008.09004.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Digital ulcers (DU) are a major complication in the course of systemic sclerosis (SSc). In recent years, efficacious, but expensive therapies (e. g. iloprost, sildenafil, bosentan) have been shown to improve healing or to reduce the recurrence of DU. For optimal management it would be useful to identify the risk factors for DU. Such statistical analyses have been rare because they require a high number of patients. Objectives To identify potential risk factors for DU in patients with SSc. Methods We used the registry of the German Network for Systemic Scleroderma and evaluated the data of 1881 patients included by August 2007. We assessed potential risk factors for DU by comparing patients with (24.1%) and without active DU at time of entry (75.9%). Results Multivariate analysis revealed that male sex, presence of pulmonary arterial hypertension (PAH), involvement of the oesophagus, diffuse skin sclerosis (only when PAH was present), anti-Scl70 antibodies, young age at onset of Raynaud's phenomenon (RP), and elevated erythrocyte sedimentation rate (ESR) significantly impacted on the appearance of DU. Certain combinations increased the patients' probability of presenting with DU, with the highest probability (88%) for male patients with early onset of RP, ESR > 30 mm h(-1), anti-Scl70 antibodies and PAH. Patients with DU developed RP, skin sclerosis and organ involvement approximately 2-3 years earlier than patients without DU. Conclusions The results reveal possible risk factors for the occurrence of DU in SSc. As DU are prone to local complications, prophylactic vasoactive treatment for patients presenting with these factors may be justified.
引用
收藏
页码:835 / 843
页数:9
相关论文
共 50 条
  • [41] Associations of Digital Ulcers in Patients with Systemic Sclerosis: An 8-Year Retrospective Study
    Chi, Miaomiao
    An, Qi
    Feng, Xiuyuan
    He, Lan
    Pan, Ying
    DERMATOLOGY, 2024, 240 (03) : 387 - 396
  • [42] Maresin1 is a predictive marker of new digital ulcers in systemic sclerosis patients
    Pellicano, Chiara
    Romaggioli, Laura
    Miglionico, Marzia
    Colalillo, Amalia
    Ramaccini, Cesarina
    Gigante, Antonietta
    Muscaritoli, Maurizio
    Rosato, Edoardo
    MICROVASCULAR RESEARCH, 2022, 142
  • [43] Digital Ulcers in Systemic Sclerosis - an Interdisciplinary Challenge
    Wiesent, Franziska
    Weinerth, Jutta
    MEDIZINISCHE KLINIK, 2010, 105 (08) : 578 - 581
  • [44] Bosentan For Digital Ulcers in Patients With Systemic Sclerosis: Single Center Experience
    Kucuksahin, Orhan
    Yildizgoren, Mustafa Turgut
    Gerede, Demet Menekse
    Maras, Yuksel
    Erten, Sukran
    ARCHIVES OF RHEUMATOLOGY, 2016, 31 (03): : 229 - 233
  • [45] Risk of digital ulcers occurrence in systemic sclerosis: a cross-sectional study
    Alex Magno Coelho Horimoto
    Albert Schiaveto de Souza
    Silvia Helena Rodrigues
    Cristiane Kayser
    Advances in Rheumatology, 59
  • [46] Treatment of Vascular Complications in Systemic Sclerosis What Is the Best Approach to Diagnosis and Management of Renal Crisis and Digital Ulcers?
    Hughes, Michael
    Herrick, Ariane L.
    Hudson, Marie
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2023, 49 (02) : 263 - 277
  • [47] Digital ulcers in systemic sclerosis: role of flow-mediated dilatation and capillaroscopy as risk assessment tools
    Ivone Silva
    Tiago Loureiro
    Andreia Teixeira
    Isabel Almeida
    Armando Mansilha
    Carlos Vasconcelos
    Rui Almeida
    European Journal of Dermatology, 2015, 25 : 444 - 451
  • [48] Digital ulcers in systemic sclerosis: role of flow-mediated dilatation and capillaroscopy as risk assessment tools
    Silva, Ivone
    Loureiro, Tiago
    Teixeira, Andreia
    Almeida, Isabel
    Mansilha, Armando
    Vasconcelos, Carlos
    Almeida, Rui
    EUROPEAN JOURNAL OF DERMATOLOGY, 2015, 25 (05) : 444 - 451
  • [49] Should all digital ulcers be included in future clinical trials of systemic sclerosis-related digital vasculopathy?
    Hughes, Michael
    Murray, Andrea
    Denton, Christopher P.
    Herrick, Ariane L.
    MEDICAL HYPOTHESES, 2018, 116 : 101 - 104
  • [50] Surgical management of digital ulcers in systemic sclerosis: A systematic literature review
    Suliman, Yossra A.
    Campochiaro, Corrado
    Hughes, Michael
    Schoones, Jan W.
    Giuggioli, Dilia
    Moinzadeh, Pia
    Baron, Murray
    Chung, Lorinda
    Ross, Laura
    Maltez, Nancy
    Allanore, Yannick
    Denton, Christopher P.
    Distler, Oliver
    Frech, Tracy
    Furst, Daniel E.
    Khanna, Dinesh
    Krieg, Thomas
    Kuwana, Masataka
    Matucci-Cerinic, Marco
    Pope, Janet
    Alunno, Alessia
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 63